Anthony Garcia-Prats

Associate Professor

University of Wisconsin School of Medicine and Public Health

United States

Research Interests

Explore related searches

Professors in United States Professors in Drug Delivery Drug Delivery professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anthony Garcia-Prats is an Associate Professor at the School of Medicine and Public Health, University of Wisconsin-Madison, USA. His research focuses on pharmacokinetics and dosing strategies for tuberculosis treatment, particularly in children and adolescents. Recent publications include studies on optimizing dosing for various antituberculosis medications and addressing the acceptability of tuberculosis treatment in pediatric populations.

Articles (13)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Muhammad Osman

University of Greenwich

UNITED KINGDOM

View details

James A. Seddon

UNITED KINGDOM

View details

Jay Achar

Karolinska Institutet

SWEDEN

View details

Elin Svensson

Professor

Uppsala University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anthony Garcia-Prats

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Model‐Informed Once‐Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis

Linezolid Pharmacokinetic-Anemia Modeling in Children With Rifampicin-Resistant Tuberculosis

Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers

Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children

Erratum for van der Laan et al., “Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis”

QT Interval Prolongation and Second-line Antituberculosis Medicines in Children: An Update and Practical Considerations for Noncardiologists

Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis

Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities

Toward a conceptual framework of the acceptability of tuberculosis treatment in children using a theory generative approach

Pharmacokinetics and Dose Optimization Strategies of Para-Aminosalicylic Acid in Children with Rifampicin-Resistant Tuberculosis

Drug concentration at the site of disease in children with pulmonary tuberculosis

Delamanid Added to an Optimized Background Regimen in Children with Multidrug-Resistant Tuberculosis: Results of a Phase I/II Clinical Trial

Tuberculosis in children with severe acute malnutrition

Collaborators (4)

Muhammad Osman

James A. Seddon

Jay Achar

Elin Svensson

Make your next move.